CytomX Therapeutics (CTMX) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for CytomX Therapeutics (CTMX) over the last 12 years, with Q3 2025 value amounting to $165.1 million.
- CytomX Therapeutics' Shares Outstanding rose 11099.85% to $165.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $165.1 million, marking a year-over-year increase of 11099.85%. This contributed to the annual value of $80.1 million for FY2024, which is 1900.0% up from last year.
- CytomX Therapeutics' Shares Outstanding amounted to $165.1 million in Q3 2025, which was up 11099.85% from $164.9 million recorded in Q2 2025.
- CytomX Therapeutics' Shares Outstanding's 5-year high stood at $165.1 million during Q3 2025, with a 5-year trough of $65.0 million in Q1 2021.
- Its 5-year average for Shares Outstanding is $79.3 million, with a median of $66.8 million in 2023.
- Its Shares Outstanding has fluctuated over the past 5 years, first surged by 60.84% in 2022, then skyrocketed by 11110.62% in 2025.
- Quarter analysis of 5 years shows CytomX Therapeutics' Shares Outstanding stood at $65.4 million in 2021, then grew by 1.28% to $66.2 million in 2022, then grew by 1.63% to $67.3 million in 2023, then increased by 19.0% to $80.1 million in 2024, then soared by 106.08% to $165.1 million in 2025.
- Its last three reported values are $165.1 million in Q3 2025, $164.9 million for Q2 2025, and $80.6 million during Q1 2025.